Haemonetics Corporation (HAE) has a MoatMap StockRank of 89/100 based on Quality (65/100), Value (58/100), and Momentum (47/100) factor scores. The current signal is STRONG BUY. Haemonetics Corporation, a US healthcare company specializing in blood management solutions, could be a quality business with specialized products and switching costs. However, it lacks a clear, asymmetric macro tailwind from the identified themes that would create an unpriced opportunity for significant outperformance beyond its inherent quality.